Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Singular Health Group Ltd ( (AU:SHG) ) has provided an announcement.
Singular Health Group Ltd announced the issuance of 8,095,805 fully paid ordinary shares, resulting from various transactions including investments, option exercises, performance rights conversions, and consulting services. This move is part of the company’s broader strategy to enhance its financial position and operational capabilities, potentially impacting its market presence and stakeholder interests.
The most recent analyst rating on (AU:SHG) stock is a Sell with a A$0.50 price target. To see the full list of analyst forecasts on Singular Health Group Ltd stock, see the AU:SHG Stock Forecast page.
More about Singular Health Group Ltd
Singular Health Group Ltd is a Western Australian, ASX-listed medical technology company focused on creating an integrated healthcare ecosystem. Its primary product, the 3Dicom software, empowers patients and practitioners to visualize and understand medical imaging data, with 3Dicom MD cleared for diagnostic use in the United States.
Average Trading Volume: 1,032,265
Technical Sentiment Signal: Buy
Current Market Cap: A$91.34M
For a thorough assessment of SHG stock, go to TipRanks’ Stock Analysis page.